PEAK6 Investments’s PRA Health Sciences, Inc. PRAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-2,600
Closed -$326K 5841
2020
Q4
$326K Sell
2,600
-7,700
-75% -$861K ﹤0.01% 3432
2020
Q3
$1.04M Sell
10,300
-900
-8% -$91.8K ﹤0.01% 2228
2020
Q2
$1.09M Buy
11,200
+9,500
+559% +$884K ﹤0.01% 2004
2020
Q1
$141K Buy
+1,700
New +$166K ﹤0.01% 3104
2019
Q4
Sell
-5,200
Closed -$516K 4311
2019
Q3
$516K Sell
5,200
-81,400
-94% -$8.08M ﹤0.01% 2255
2019
Q2
$8.59M Sell
86,600
-23,400
-21% -$2.23M 0.06% 420
2019
Q1
$12.1M Buy
+110,000
New +$11.5M 0.07% 303

Other funds holding PRAH

PEAK6 Investments's PRAH Position: Q2 2021 in Review

PEAK6 Investments sold out of PRA Health Sciences, Inc. (PRAH) in Q2 2021, closing a stake of 11,008 shares — an estimated $1.69M sold.

PEAK6 Investments first reported a position in PRAH in Q3 2018 and held it in 9 quarters. The position peaked at $6.08M in Q2 2019. 317 funds tracked by Wall St. Rank hold PRAH as of Q2 2021.

  • PEAK6 Investments reported no remaining PRA Health Sciences, Inc. position as of Q2 2021 after selling out during the quarter.
  • PEAK6 Investments sold 11,008 PRA Health Sciences, Inc. shares in Q2 2021, an estimated $1.69M.
  • PEAK6 Investments first reported a position in PRA Health Sciences, Inc. in Q3 2018 and held it in 9 quarters.
  • PEAK6 Investments's PRA Health Sciences, Inc. position peaked at $6.08M in Q2 2019.
  • 317 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q2 2021.

Based on PEAK6 Investments's 13F filing for Q2 2021, filed 13 Aug 2021.